Guest guest Posted February 24, 2011 Report Share Posted February 24, 2011 News new results for Hepatitis Lawyer presses for delay in trial of nurses connected to hepatitis C outbreak Las Vegas Review-Journal By Jeff German A courtroom tongue-lashing from a district judge has not stopped defense attorney Cristalli from seeking to delay the March 14 trial of two nurse anesthetists charged in the 2007 hepatitis C outbreak. ... See all stories on this topic » Dynavax gets thumbs up from safety panel for hepatitis vaccine tests San Francisco Business Times Dynavax Technologies Corp. got approval from a data safety monitoring board to continue two Phase III tests of its hepatitis B vaccine Heplisav. Patients in the two tests are now eight months past their last dose of the vaccine. ... See all stories on this topic » Vertex Pipeline Shows Clear Potential Beyond Hepatitis C Morningstar.com by Andersen, CFA | 02-23-11 | 11:22AM | E-mail Note Vertex Pharmaceuticals' VRTX shares moved up sharply after the firm released results from a Phase III study of VX-770 in cystic fibrosis. We already assign the drug a 60% probability of gaining ... See all stories on this topic » New vaccine technology protects mice from hepatitis C virus ScienceBlog.com (blog) Immunology: Three percent of the world's population is currently infected by hepatitis C. The virus hides in the liver and can cause cirrhosis and liver cancer, and it's the most frequent cause of liver transplants in Denmark. ... See all stories on this topic » Treatment available locally for Hepatitis C Sarnia Observer There are hundreds, if not thousands of people suffering from Hepatitis C in Sarnia-Lambton, says a registered nurse who's started offering treatment options locally. Sonja Gould, a nurse manager at the Bluewater Methadone Clinic, is offering viral ... See all stories on this topic » Health and Science: People from SE Asia should be screened for Hepatitis C The Muslim News By Kayani Many people born in SE Asia may be infected with the Hepatitis C virus without even knowing it. Hepatitis C is caused by a virus carried and passed on through blood; it can be picked up through needles and medical equipment that have ... See all stories on this topic » J & J hepatitis C drug begins phase III trials InPharm & has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the virus. TMC435 will be investigated in around 1200 treatment-naïve patients with chronic genotype 1 hepatitis C virus (HCV). ... See all stories on this topic » Brief : Hepatitis C/AASLD 2010 available through bharatbook.com PRLog.Org (press release) PRLog (Press Release) – Feb 23, 2011 – Bharatbook.com announces inclusion of latest report on " Brief : Hepatitis C/AASLD 2010 " ( http://www.bharatbook.com/detail.asp?id=173540 & rt=Brief-Hepatitis-C-AASLD-2010.h\ tml )Data from Phase III studies for ... See all stories on this topic » Enhanced specific immune responses by CpG DNA in mice immunized with ... 7thSpace Interactive (press release) Hepatitis B vaccine adjuvant, alum, is generally used for vaccination although it does not stimulate Th1 immunity and 10% of the population has low or no antibody response. Efforts have been continued to find more efficient vaccine adjuvants for better ... See all stories on this topic » ACIP urges pertussis vaccination for health workers CIDRAP In later action, the ACIP discussed and approved a revision of the general immunization recommendations for HCPs, after dropping a clause calling for documenting immunity to hepatitis B in workers who are exposed to blood and other bodily fluids. ... See all stories on this topic » Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.